TrialClinical orthopaedics and related research2016

Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.

Hoon Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.